Search research articles
Contact Us
Filters
Showing results (241-250 of 295) with videos related to
Page
of 30
Sort By:
Clinical and Experimental Rheumatology
|
October 3, 2009
Vitamin E gel reduces time of healing of digital ulcers in systemic sclerosis
G Fiori, F Galluccio, F Braschi, et al.
Arthritis and Rheumatism
|
November 17, 2001
Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis
O Distler, T Pap, O Kowal-Bielecka, et al.
Clinical Rheumatology
|
February 23, 2018
The safety of iloprost in systemic sclerosis in a real-life experience
S Bellando-Randone, C Bruni, G Lepri, et al.
Annals of the Rheumatic Diseases
|
December 8, 2007
Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study
B Rozman, S Cucnik, S Sodin-Semrl, et al.
Clinical and Experimental Rheumatology
|
August 11, 2004
The expression of cyclooxygenase-1, cyclooxygenase-2 and 5-lipoxygenase in inflammatory muscle tissue of patients with polymyositis and dermatomyositis
J T Studýnková, S Kuchen, E Jeisy, et al.
Annals of the Rheumatic Diseases
|
July 26, 2008
EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells
J H W Distler, Y Allanore, J Avouac, et al.
Reumatismo
|
March 8, 2021
Pulmonary arterial hypertension: guidelines and unmet clinical needs
D Giuggioli, C Bruni, F Cacciapaglia, et al.
Rheumatology (Oxford, England)
|
February 1, 2007
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis
F Bartoli, C Angotti, C Fatini, et al.
Rheumatology (Oxford, England)
|
August 30, 2008
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy
I Olivieri, S de Portu, C Salvarani, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 7, 2013
Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implications
E Romano, M Manetti, F Peruzzi, et al.
Page
of 30
Search research articles
Search
Showing results (241-250 of 295) with videos related to
Sort By:
Page
of 30
Clinical and Experimental Rheumatology
|
October 3, 2009
Vitamin E gel reduces time of healing of digital ulcers in systemic sclerosis
G Fiori, F Galluccio, F Braschi, et al.
Arthritis and Rheumatism
|
November 17, 2001
Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis
O Distler, T Pap, O Kowal-Bielecka, et al.
Clinical Rheumatology
|
February 23, 2018
The safety of iloprost in systemic sclerosis in a real-life experience
S Bellando-Randone, C Bruni, G Lepri, et al.
Annals of the Rheumatic Diseases
|
December 8, 2007
Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study
B Rozman, S Cucnik, S Sodin-Semrl, et al.
Clinical and Experimental Rheumatology
|
August 11, 2004
The expression of cyclooxygenase-1, cyclooxygenase-2 and 5-lipoxygenase in inflammatory muscle tissue of patients with polymyositis and dermatomyositis
J T Studýnková, S Kuchen, E Jeisy, et al.
Annals of the Rheumatic Diseases
|
July 26, 2008
EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells
J H W Distler, Y Allanore, J Avouac, et al.
Reumatismo
|
March 8, 2021
Pulmonary arterial hypertension: guidelines and unmet clinical needs
D Giuggioli, C Bruni, F Cacciapaglia, et al.
Rheumatology (Oxford, England)
|
February 1, 2007
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis
F Bartoli, C Angotti, C Fatini, et al.
Rheumatology (Oxford, England)
|
August 30, 2008
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy
I Olivieri, S de Portu, C Salvarani, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 7, 2013
Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implications
E Romano, M Manetti, F Peruzzi, et al.
Page
of 30